Magistral formulations and pruritus therapy - What is established, what is confirmed, what is new?;Magistralrezeptur und Pruritustherapie - Was ist etabliert, was hat sich bewährt, was ist neu?

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue 11, 2013, Pages 1049-1055

  Staubach, Petra ^a   Metz, Martin ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CAMPHOR; CAYENNE PEPPER EXTRACT; CHLORHEXIDINE GLUCONATE; COAL TAR UREA; COSMETIC; DILTIAZEM; ICHTHAMMOL; MENTHOL; METHOXSALEN; POLIDOCANOL; SALICYLIC ACID; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UREA; ZINC OXIDE;

DISEASE CLASSIFICATION; DRUG FORMULATION; HUMAN; MAGISTRAL FORMULATION; PHARMACIST; PHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRURITUS; PUVA; REVIEW; SCRATCHING; SKIN DEFECT; SYSTEMIC THERAPY;

DERMATOLOGIC AGENTS; DRUG COMPOUNDING; EVIDENCE-BASED MEDICINE; HUMANS; PRURITUS; TREATMENT OUTCOME;

EID: 84886028278     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12230     Document Type: Review

References (19)

1. Ständer S, Schäfer I, Phan NQ,. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11 730. Dermatology 2010; 221 (3): 229-35.
2. Matterne U, Apfelbacher CJ, Vogelgsang L,. Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol 2013; 11: 115.
3. Misery L, Rahhali N, Duhamel A, Taieb C,. Epidemiology of dandruff, scalp pruritus and associated symptoms. Acta Derm Venereol 2013; 93 (1): 8.
4. Ständer S, Darsow U, Mettang T,. S2k guideline-Chronic Pruritus. J Dtsch Dermatol Ges 2012; 4: S1-27.
5. Weisshaar E, Szepietowski JC, Darsow U,. European guideline on chronic pruritus. Acta Derm Venereol 2012; 92: 449-81.
6. Wolf G,. Amendment to the pharmacy operations regulation 2012. New regulations in the field of dermatological formulations. Hautarzt 2012; 63 (8): 606-7.
7. Neues-Rezeptur-Formularium (NRF). Loseblattsammlung auf dem Stand (2012), 6. Auflage, Eschborn: Govi-Verlag Pharmazeutischer Verlag / Stuttgart: Deutscher Apotheker-Verlag 2012.
8. Staubach P, Reimann H, Gehring W, Leitner E,. Leitlinie: Dermatologische Rezepturen. Gesellschaft für Dermopharmazie 2013.
9. Ständer S, Weisshaar E, Metang T,. Clinical classification of itch: a position paper of the international Forum for the Study of Itch. Acta derm Vernereol 2007; 87 (4): 291-4.
10. Garbe C, Reimann H,. Dermatologische Rezepturen, 2nd Edition, Georg Thieme Verlag, Stuttgart, 2007.
11. Höger PH,. Kinderdermatologie-Differentialdiagnostik und Therapie bei Kindern und Jugendlichen. 3rd Edition, Schattauer Verlag, Stuttgart, New York, 2011.
12. Zhai H, Frisch S, Pelosi A,. Antipruritic and thermal sensation effects of hydrocortisone creams in human skin. Skin Pharmacol Appl Skin Physiol 2000; 13: 352-7.
13. Knight J., Birks M, Farouk R,. Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg 2001; 88: 553-6.
14. Nast A, BWH, Mrowietz U, Ockenfels HM,. S3-guidelines on the treatment of psoriasis vulgaris-Update. J Dtsch Dermatol Ges 2012; 10 Suppl 2: S1-95.
15. Wallengren J,. Prurigo. Diagnosis and Management. Am J Clin Dermatol 2004; 5 (2): 85-95.
16. Gambichler T, Hyun J, Sommer A,. A randomized controlled trial on photo(chemo)therapy of subacute prurigo. Clin Exp Dermatol 2006; 31 (3): 348-53.
17. Ständer S,. Rationelle symptomatische Therapie bei chronischem Pruritus. Hautarzt 2006; 57: 403-10.
18. Ständer S, Metze D,. Treatment of pruritic skin diseases with topical capsaicin. In:, Yosipovitch G, Greaves MW, Fleischer AB, McGlone F,: Itch: Basic mechanisms and therapy. New York: Marcel Dekker, 2005; 287-304.
19. Przybilla B, Ruëff F,. Insect Stings: Clinical Features and Management. Dtsch Arztebl Int 2012; 109 (13): 238-48.